Skip to main content
Top
Published in: Supportive Care in Cancer 1/2013

01-01-2013 | Original Article

Symptoms in advanced pancreatic cancer are of importance for energy intake

Authors: Asta Bye, Marit S. Jordhøy, Grete Skjegstad, Oddlaug Ledsaak, Per Ole Iversen, Marianne Jensen Hjermstad

Published in: Supportive Care in Cancer | Issue 1/2013

Login to get access

Abstract

Purpose

Cancer cachexia and low energy intake (EI) probably contribute to weight loss in advanced pancreatic cancer (PC). However, little is known about the actual EI in this disease. Aims were to assess EI, weight loss and symptoms during the disease course and investigate associations between symptoms and EI.

Methods

Thirty-nine patients (21 males) with advanced PC were consecutively included and followed every 4 weeks until the end of life. A 24-h dietary recall was used to assess EI. The Edmonton Symptom Assessment System (ESAS) and the PC-specific health-related quality of life questionnaire (QLQ-PAN26) were used for symptom assessment.

Results

Median age was 62 years (48–88), WHO performance status 1 (0–2) and survival 5 months (1–25). Seventeen (44 %) patients had unresectable cancer, 16 (41 %) metastatic and six (15 %) recurrent disease. Upon inclusion, 37 (95 %) reported weight loss (median 4.0 kg per month). During follow-up, median weight loss per month was <1.0 kg. Forty to 65 % had EI <29 kcal/kg/day (cut-off value for weight maintenance) during the observation period but they did not lose more weight than patients with EI ≥ 29 kcal. Strong negative correlations (r range) were found between EI and pain (0.51–0.61), fatigue (0.54–0.67), oral dryness (0.61–0.64) and loss of appetite (0.53–0.71).

Conclusion

In this study, several symptoms influenced EI negatively. Low EI did not completely explain weight loss in this patient group, but careful monitoring and early follow-up of symptoms may be important interventions to reduce weight loss in advanced PC.
Literature
1.
go back to reference Wigmore SJ, Plester CE, Richardson RA, Fearon KC (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75(1):106–109PubMedCrossRef Wigmore SJ, Plester CE, Richardson RA, Fearon KC (1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75(1):106–109PubMedCrossRef
3.
go back to reference Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495 Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489-495
4.
go back to reference Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46. doi:10.1007/s00520-006-0091-0 PubMedCrossRef Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15(1):39–46. doi:10.​1007/​s00520-006-0091-0 PubMedCrossRef
5.
go back to reference Bovio G, Bettaglio R, Bonetti G, Miotti D, Verni P (2008) Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care. Minerva Gastroenterol Dietol 54(3):243–250PubMed Bovio G, Bettaglio R, Bonetti G, Miotti D, Verni P (2008) Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care. Minerva Gastroenterol Dietol 54(3):243–250PubMed
7.
go back to reference Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, Stone P, Kaasa S, Fearon K, Strasser F Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol/Hematol, Corrected Proof. doi:DOI: 10.1016/j.critrevonc.2010.10.004 Blum D, Omlin A, Baracos VE, Solheim TS, Tan BHL, Stone P, Kaasa S, Fearon K, Strasser F Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol/Hematol, Corrected Proof. doi:DOI: 10.​1016/​j.​critrevonc.​2010.​10.​004
8.
go back to reference Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A (2009) Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 17(12):1531–1541. doi:10.1007/s00520-009-0623-5 PubMedCrossRef Yavuzsen T, Walsh D, Davis MP, Kirkova J, Jin T, LeGrand S, Lagman R, Bicanovsky L, Estfan B, Cheema B, Haddad A (2009) Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia. Support Care Cancer 17(12):1531–1541. doi:10.​1007/​s00520-009-0623-5 PubMedCrossRef
10.
go back to reference Damerla V, Gotlieb V, Larson H, Saif MW (2008) Pancreatic enzyme supplementation in pancreatic cancer. J Support Oncol 6(8):393–396PubMed Damerla V, Gotlieb V, Larson H, Saif MW (2008) Pancreatic enzyme supplementation in pancreatic cancer. J Support Oncol 6(8):393–396PubMed
11.
go back to reference Perez MM, Newcomer AD, Moertel CG, Go VL, Dimagno EP (1983) Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer 52(2):346–352PubMedCrossRef Perez MM, Newcomer AD, Moertel CG, Go VL, Dimagno EP (1983) Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer 52(2):346–352PubMedCrossRef
12.
go back to reference Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG (2005) Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103(10):2189–2198PubMedCrossRef Fouladiun M, Korner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG (2005) Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103(10):2189–2198PubMedCrossRef
15.
go back to reference Ferrucci L, Bell D, Thornton J, Black G, McCorkle R, Heimburger D, Saif M (2010) Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer:1-6. doi:10.1007/s00520-010-1011-x Ferrucci L, Bell D, Thornton J, Black G, McCorkle R, Heimburger D, Saif M (2010) Nutritional status of patients with locally advanced pancreatic cancer: a pilot study. Support Care Cancer:1-6. doi:10.​1007/​s00520-010-1011-x
16.
go back to reference Blaker B, Aarsland M (1989) Mål og vekt for matvarer. Landsforeningen for kosthold & helse, [Oslo] Blaker B, Aarsland M (1989) Mål og vekt for matvarer. Landsforeningen for kosthold & helse, [Oslo]
18.
go back to reference Fagerli RA (2008) Matvaretabellen. Gyldendal undervisning, Oslo Fagerli RA (2008) Matvaretabellen. Gyldendal undervisning, Oslo
19.
go back to reference Saxholt E, Christensen AT, Møller A, Hartkopp HB, Hess Ygil, K, Hels, OH (2008) Danish food composition databank, revision 7 Saxholt E, Christensen AT, Møller A, Hartkopp HB, Hess Ygil, K, Hels, OH (2008) Danish food composition databank, revision 7
21.
go back to reference Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed
22.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef
23.
go back to reference Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, Buchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35(6):939–941PubMedCrossRef Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C, Beger HG, Birk D, Buchler MW, Dervenis C, Fernandez Cruz L, Friess H, Grahm AL, Jeekel J, Laugier R, Meyer D, Singer MW, Tihanyi T (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35(6):939–941PubMedCrossRef
24.
go back to reference Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, Chow E (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag 39(2):241–249CrossRef Selby D, Cascella A, Gardiner K, Do R, Moravan V, Myers J, Chow E (2010) A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. J Pain Symptom Manag 39(2):241–249CrossRef
25.
go back to reference Marin Caro MM, Laviano A, Pichard C (2007) Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10(4):480–487PubMedCrossRef Marin Caro MM, Laviano A, Pichard C (2007) Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10(4):480–487PubMedCrossRef
26.
go back to reference Tong H, Isenring E, Yates P (2009) The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 17(1):83–90PubMedCrossRef Tong H, Isenring E, Yates P (2009) The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 17(1):83–90PubMedCrossRef
27.
go back to reference Fayers PMAN, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual 3rd edn. EORTC Quality of Life Group Brussels, Belgium Fayers PMAN, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual 3rd edn. EORTC Quality of Life Group Brussels, Belgium
28.
go back to reference Cohen J (1988) Statistical power analysis for the behavioral sciences. Laurence Erlbaum, Hillsdale Cohen J (1988) Statistical power analysis for the behavioral sciences. Laurence Erlbaum, Hillsdale
29.
go back to reference Bovio G, Montagna G, Bariani C, Baiardi P (2009) Upper gastrointestinal symptoms in patients with advanced cancer: relationship to nutritional and performance status. Support Care Cancer 17(10):1317–1324PubMedCrossRef Bovio G, Montagna G, Bariani C, Baiardi P (2009) Upper gastrointestinal symptoms in patients with advanced cancer: relationship to nutritional and performance status. Support Care Cancer 17(10):1317–1324PubMedCrossRef
30.
go back to reference Gibson RS (2005) Principles of nutritional assessment. Oxford University Press, New York Gibson RS (2005) Principles of nutritional assessment. Oxford University Press, New York
31.
go back to reference Johnson G, Salle A, Lorimier G, Laccourreye L, Enon B, Blin V, Jousset Y, Arnaud J-P, Malthiery Y, Simard G, Ritz P (2008) Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition 24(5):443–450PubMedCrossRef Johnson G, Salle A, Lorimier G, Laccourreye L, Enon B, Blin V, Jousset Y, Arnaud J-P, Malthiery Y, Simard G, Ritz P (2008) Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition 24(5):443–450PubMedCrossRef
32.
go back to reference Bosaeus I (2008) Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 16(5):447–451PubMedCrossRef Bosaeus I (2008) Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 16(5):447–451PubMedCrossRef
33.
go back to reference Berry DP, Charnley RM, Dervenis C, Kirk GR, Regan F, Yekebas EF, Imrie CW (2011) Pain management and nutritional support in nonresectable pancreatic cancer. In: Johnson CD, Imrie CW (eds) Pancreatic disease. Springer London, pp 73-77. doi:10.1007/978-1-84882-118-7_8 Berry DP, Charnley RM, Dervenis C, Kirk GR, Regan F, Yekebas EF, Imrie CW (2011) Pain management and nutritional support in nonresectable pancreatic cancer. In: Johnson CD, Imrie CW (eds) Pancreatic disease. Springer London, pp 73-77. doi:10.​1007/​978-1-84882-118-7_​8
34.
go back to reference Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ (1998) Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 42(1):92–96PubMedCrossRef Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ (1998) Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 42(1):92–96PubMedCrossRef
35.
36.
go back to reference Petruson KM, Silander EM, Hammerlid EB (2005) Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck 27(4):302–310PubMedCrossRef Petruson KM, Silander EM, Hammerlid EB (2005) Quality of life as predictor of weight loss in patients with head and neck cancer. Head Neck 27(4):302–310PubMedCrossRef
37.
go back to reference Chang VT, Xia Q, Kasimis B (2005) The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3(5):377–382PubMed Chang VT, Xia Q, Kasimis B (2005) The functional assessment of anorexia/cachexia therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3(5):377–382PubMed
38.
go back to reference Chate A (2006) A pilot audit of weight loss in upper gastrointestinal oncology outpatients. J Hum Nutr Diet 19(6):447–450PubMedCrossRef Chate A (2006) A pilot audit of weight loss in upper gastrointestinal oncology outpatients. J Hum Nutr Diet 19(6):447–450PubMedCrossRef
40.
go back to reference Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38(7):680–685PubMedCrossRef Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38(7):680–685PubMedCrossRef
41.
go back to reference Sreebny LM, Schwartz SS (1997) A reference guide to drugs and dry mouth—2nd edition. Gerodontology 14(1):33–47PubMedCrossRef Sreebny LM, Schwartz SS (1997) A reference guide to drugs and dry mouth—2nd edition. Gerodontology 14(1):33–47PubMedCrossRef
42.
go back to reference Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11(4):226–231PubMed Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11(4):226–231PubMed
45.
go back to reference Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163PubMedCrossRef Boltong A, Keast R (2012) The influence of chemotherapy on taste perception and food hedonics: a systematic review. Cancer Treat Rev 38(2):152–163PubMedCrossRef
Metadata
Title
Symptoms in advanced pancreatic cancer are of importance for energy intake
Authors
Asta Bye
Marit S. Jordhøy
Grete Skjegstad
Oddlaug Ledsaak
Per Ole Iversen
Marianne Jensen Hjermstad
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 1/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1514-8

Other articles of this Issue 1/2013

Supportive Care in Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine